Counseling service for new type 2 diabetes medication
Effects of Medisinstart for Type 2 Diabetes
NA · Apokus AS · NCT06273657
This study tests whether a new counseling service in pharmacies can help people starting a new type 2 diabetes medication stick to their treatment better than just getting their prescription.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Apokus AS (other) |
| Locations | 19 sites (Bardufoss and 18 other locations) |
| Trial ID | NCT06273657 on ClinicalTrials.gov |
What this trial studies
This project evaluates the Medisinstart counseling service in pharmacies, which provides patients starting new medications for type 2 diabetes with two follow-up appointments with a pharmacist. The goal is to enhance medication adherence and ensure proper medication use. Participants are randomly assigned to either receive the Medisinstart intervention or standard prescription dispensing. Data will be collected through blood samples for HbA1c analysis and patient questionnaires to assess the effectiveness of the intervention.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are starting a new medication for type 2 diabetes and can communicate effectively in Norwegian.
Not a fit: Patients who have had their diabetes medication initiated within the last year or those whose medication is administered by a healthcare professional may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve medication adherence and glycemic control in patients with type 2 diabetes.
How similar studies have performed: Previous studies have shown success with similar pharmacist-led interventions for other conditions, suggesting potential for positive outcomes in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Extracted a new drug/active substance (A10A/A10B) for type 2 diabetes * Age ≥ 18 years * The drugs are administered by the patient/relatives * Good command of Norwegian, both written and spoken Exclusion Criteria: * Inability to understand and/or complete consent forms, questionnaires and/or other patient-oriented materials * Not able to attend physical appointments in the pharmacy * Not given written consent to participate in the study * Diabetes medication is administered by a healthcare professional * Known pregnancy * HbA1c is unsuitable as an average measure of blood glucose at baseline * Received initiation of medication for type 2 diabetes within the last year * Ongoing participation in other studies involving similar interventions to increase adherence and ensure correct medication use
Where this trial is running
Bardufoss and 18 other locations
- Apotek 1 Andslimoen — Bardufoss, Norway (RECRUITING)
- Apotek 1 Brandbu — Brandbu, Norway (RECRUITING)
- Apotek 1 Brummundal — Brumunddal, Norway (RECRUITING)
- Sykehusapoteket i Drammen — Drammen, Norway (RECRUITING)
- Vitusapotek Gjøvik — Gjøvik, Norway (RECRUITING)
- Vitusapotek Jessheim — Jessheim, Norway (RECRUITING)
- Boots apotek Kløfta — Kløfta, Norway (RECRUITING)
- Vitusapotek Leksvik — Leksvik, Norway (RECRUITING)
- Apotek 1 Lena — Lena, Norway (RECRUITING)
- Boots apotek Loddefjord — Loddefjord, Norway (RECRUITING)
- Sykehusapoteket i Oslo, Aker — Oslo, Norway (RECRUITING)
- Vitusapotek Røa — Oslo, Norway (RECRUITING)
- Ryfylke apotek — Rennesøy, Norway (RECRUITING)
- Vitusapotek Jekta — Tromsø, Norway (RECRUITING)
- Sykehusapoteket i Trondheim — Trondheim, Norway (RECRUITING)
- Vitusapotek Ulefoss — Ulefoss, Norway (RECRUITING)
- Apotek 1 Veakrossen — Veavåg, Norway (RECRUITING)
- Vitusapotek Åfjord — Åfjord, Norway (RECRUITING)
- Boots apotek Linnea — Øystese, Norway (RECRUITING)
Study contacts
- Principal investigator: Sara Bremer, PhD — Head of Research and Development
- Study coordinator: Sara Bremer, PhD
- Email: sara@apokus.no
- Phone: 21620200
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type 2 Diabetes, Medication related problems, Adherence, Type 2 diabetes, Pharmacist-led intervention, Consultation, Pharmacy